Delivery Order SPE2DE24DA010-SPE2D626F40M4
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $17,250 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price contract with economic price adjustment provision will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. As a child entity of Abbott Laboratories Inc., Abbott...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695 by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 6, 2026. This fixed-price delivery order with economic price adjustment carries no set-aside designation and represents a task order executed under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F40M4Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $24,350 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The order will be performed in Santa Clara, California, and represents a task order against Abbott's existing indefinite delivery contract vehicle with the Defense Logistics Agency. This award was made through full and open competition with no set-aside designation. Abbott Vascular specializes in advanced cardiovascular medical technologies and has established itself as a strategic supplier to federal healthcare systems, providing sophisticated medical devices including stents, pacemakers, heart valves, implantable cardiac monitors, and left ventricular assist devices to support military and veteran healthcare networks. The award reflects Abbott's ongoing role as a critical supplier within the federal government's medical device procurement infrastructure. The company maintains a substantial $117.1 million indefinite delivery contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages, which has generated numerous task orders throughout 2024 and 2025. Abbott's federal contracting portfolio demonstrates consistent competitive success across multiple Veterans Integrated Service Networks and federal healthcare agencies, with the company providing both discrete medical device deliveries and integrated procedural packages that include technical support and specialized assistance to medical staff.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 12/17/25 |